FDA Okays First Generics for Eliquis (Apixaban)
The FDA has approved two applications for the first generic versions of apixaban to reduce stroke and systemic embolism for patients with atrial fibrillation.
Related Articles
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Advancing the Prevention and Treatment of Heart Failure
In this free symposium, experts discuss current and emerging treatment options for the prevention and treatment of HF, across a spectrum of ejection fractions. Join…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…
Heart of Cardio
earn up to 13.25 cme/ce credits At the 4th Annual Going Back to the Heart of Cardiology, we’ll explore the latest advancements in Cardiology, from…